DALT: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject |
Tagged unsourced claim for other editors to review Tags: Visual edit Mobile edit Mobile web edit |
||
(27 intermediate revisions by 21 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Watchedfields = changed |
|||
| verifiedrevid = |
| verifiedrevid = 451559106 |
||
| IUPAC_name = ''N''- |
| IUPAC_name = ''N''-Allyl-''N''-[2-(1''H''-indol-3-yl)ethyl]prop-2-en-1-amine |
||
| image = DALT-structure.png |
| image = DALT-structure.png |
||
Line 7: | Line 9: | ||
| tradename = |
| tradename = |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_DE = NpSG |
|||
⚫ | |||
| legal_UK = Class A |
|||
⚫ | |||
| legal_US = Analogue |
|||
| legal_US_comment = (possibly) |
|||
⚫ | |||
⚫ | |||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
Line 14: | Line 20: | ||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number = |
| CAS_number = 60676-77-9 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 85113MO9BC |
|||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
Line 26: | Line 34: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=16 | H=20 | N=2 |
| C=16 | H=20 | N=2 |
||
⚫ | |||
| molecular_weight = 240.34 g/mol |
|||
⚫ | |||
| InChI = 1/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2 |
|||
| InChIKey = LQEATNFJCMVKAC-UHFFFAOYAB |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2 |
| StdInChI = 1S/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2 |
||
Line 36: | Line 41: | ||
}} |
}} |
||
'''''N'',''N''-Diallyltryptamine''' ('''DALT''') is a [[tryptamine]] [[derivative (chemistry)|derivative]] which has been identified as a new psychoactive substance.<ref name="pmid26297461">{{cite journal | vauthors = Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH | title = Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS | journal = Analytical and Bioanalytical Chemistry | volume = 407 | issue = 25 | pages = 7831–42 | date = October 2015 | pmid = 26297461 | doi = 10.1007/s00216-015-8955-0 | s2cid = 26086597 | url = http://researchonline.ljmu.ac.uk/id/eprint/3406/1/ABC-01148-2015.R1.pdf }}</ref><ref name="pmid27933361">{{cite journal | vauthors = Michely JA, Brandt SD, Meyer MR, Maurer HH | title = n, and LC-HR-MS/MS | journal = Analytical and Bioanalytical Chemistry | volume = 409 | issue = 6 | pages = 1681–1695 | date = February 2017 | pmid = 27933361 | doi = 10.1007/s00216-016-0117-5 | s2cid = 206920201 | url = http://researchonline.ljmu.ac.uk/id/eprint/4885/1/ABC_5F_7Me_5%2C6MD-DALT_accepted.pdf }}</ref> It has been used as an intermediate in the preparation of [[radiolabeled]] [[diethyltryptamine]].<ref>{{cite journal | vauthors = Brandt SD, Tirunarayanapuram SS, Freeman S, Dempster N, Barker SA, Daley PF, Cozzi NV, Martins CP | display-authors = 6 | title = Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines | journal = Journal of Labelled Compounds and Radiopharmaceuticals | date = 2008 | volume = 51 | issue = 14 | pages = 423–429 | doi = 10.1002/jlcr.1557}}</ref> |
|||
'''''N'',''N''-Diallyltryptamine''' ('''DALT''') is a [[psychedelic drug|psychedelic]] [[drug]] of the [[tryptamine]] class.<ref name="urlThe Psychedelic Index - DALT (ahead of print)">{{cite web | url = http://www.bluelight.ru/vb/showpost.php?p=2104770&postcount=15 | title = The Psychedelic Index - DALT (ahead of print) | author = Alexander Shulgin | coauthor = Ann Shulgin | accessdate = April 2010}}</ref> [[Alexander Shulgin]] reports that DALT is active at 42 mg [[mouth|orally]], producing a +1 on the [[Shulgin scale]], and being back to baseline by 4 hours.<ref name="urlThe Psychedelic Index - DALT (ahead of print)">{{cite web | url = http://www.bluelight.ru/vb/showpost.php?p=2104770&postcount=15 | title = The Psychedelic Index - DALT (ahead of print) | author = Alexander Shulgin | coauthor = Ann Shulgin | accessdate = April 2010}}</ref> It is said to have a similar [[potency (pharmacology)|potency]] to [[N,N-dimethyltryptamine|DMT]], being [[activity (chemistry)|active]] at doses of approximately 40-100 mg, and to have a duration of about 2-4 hours.<ref name="urlThe Psychedelic Index - DALT (ahead of print)">{{cite web | url = http://www.bluelight.ru/vb/showpost.php?p=2104770&postcount=15 | title = The Psychedelic Index - DALT (ahead of print) | author = Alexander Shulgin | coauthor = Ann Shulgin | accessdate = April 2010}}</ref> Relative to the other tryptamine psychedelics, DALT and [[5-MeO-DALT]] are said to be much weaker and far more gentle in comparison.<ref name="urlThe Psychedelic Index - DALT (ahead of print)">{{cite web | url = http://www.bluelight.ru/vb/showpost.php?p=2104770&postcount=15 | title = The Psychedelic Index - DALT (ahead of print) | author = Alexander Shulgin | coauthor = Ann Shulgin | accessdate = April 2010}}</ref><ref name="urlBluelight Forums - The Big & Dandy 5-MeO-DALT Thread - Page 1">{{cite web | url = http://www.bluelight.ru/vb/showthread.php?t=146249 | title = Bluelight Forums - The Big & Dandy 5-MeO-DALT Thread - Page 1 | format = HTML | accessdate = April 2010}}</ref>{{Verify credibility|date=September 2011}} However, if [[smoked]], they may be more comparable to DMT and the like, potentially capable of producing 'breakthrough' experiences.<ref name="urlBluelight Forums - The Big & Dandy 5-MeO-DALT Thread - Page 4">{{cite web | url = http://www.bluelight.ru/vb/showthread.php?t=146249&page=4 | title = Bluelight Forums - The Big & Dandy 5-MeO-DALT Thread - Page 4 | format = HTML | accessdate = April 2010}}</ref>{{Verify credibility|date=September 2011}} |
|||
One of the more pronounced effects of this substance is a sharp increase in body temperature, similar to the effects of 2,4-Dinitrophenol (DNP). Unlike DNP, DALT is suggested to be safer, as it belongs to the tryptamine family. DALT exhibits weak psychoactive properties, particularly among tryptamines. |
|||
The metabolic effects of this substance on body temperature, and its non-toxic nature, leads to the viability of this substance being used for emergency situations in cold weather environments, or as a weight loss supplement.{{Citation needed|date=August 2023}} |
|||
== See also == |
== See also == |
||
* [[4-AcO-DALT]] |
|||
* [[5-MeO-DALT]] |
* [[5-MeO-DALT]] |
||
== References == |
== References == |
||
{{Reflist}} |
{{Reflist}} |
||
== External links == |
|||
* [http://isomerdesign.com/PiHKAL/explore.php?domain=tk&id=5372 isomerdesign.com - N,N-Diallyltryptamine (DALT)] |
|||
{{Hallucinogens}} |
{{Hallucinogens}} |
||
Line 53: | Line 58: | ||
[[Category:Psychedelic tryptamines]] |
[[Category:Psychedelic tryptamines]] |
||
[[Category:Designer drugs]] |
|||
[[Category:Entheogens]] |
[[Category:Entheogens]] |
||
[[Category: |
[[Category:Allyl compounds]] |